Abstract
Introduction: Description of the cutaneous side effects of erlotinib. Materials: Report with images of a single case. Methods: Case report and review of the literature. Conclusion: Erlotinib is associated with significant cutaneous toxicity which should be recognised and managed appropriately.
Original language | English (US) |
---|---|
Pages (from-to) | 283-284 |
Number of pages | 2 |
Journal | Irish journal of medical science |
Volume | 180 |
Issue number | 1 |
DOIs | |
State | Published - Mar 2011 |
Externally published | Yes |
Keywords
- EGFR inhibitors
- Erlotinib
- Hair change
- Non-small-cell lung cancer
ASJC Scopus subject areas
- General Medicine